Sentences with word «precancer»

About Proteocyte Diagnostics Proteocyte Diagnostics Inc. is a Canadian molecular diagnostics company that develops and commercializes a novel diagnostics technology, Straticyte ™ that offers objective and accurate early diagnosis of precancers and cancers.

«Vaccine used to treat cervical precancers triggers immune cell response.»

The main goal of cervical screening programs is to detect and treat precancer before cancer develops.

Pap tests can identify cervical precancer before it turns into cancer.

Any woman with a uterus who takes systemic estrogen of any type, such as a cream, patch, or pill, must counterbalance the estrogen with progesterone, delivered orally as a pill, to prevent buildup of excess tissue in the uterine lining, which may turn into precancer or cancer.

Women who have had a hysterectomy (surgery to remove the uterus and cervix) do not need to have a Pap test, unless the surgery was done as a treatment for precancer or cancer.

Women with precancer or cancer were most likely to have particular versions of the viral gene E7, which researchers are now interested in targeting.

Moreover, HPV16 had significantly fewer variants throughout the genome in precancer and cancer patients compared with control subjects with benign infections.

HPV testing is more sensitive than the Pap test for detecting precancer.

I went 10 years without fruit, but started to get precancer which went away when I ate fruit.

Proteocyte Diagnostics Inc. is a Canadian molecular diagnostics company that develops and commercializes a novel diagnostics technology, Straticyte ™ that offers objective and accurate early diagnosis of precancers and cancers.

HPV testing led to a 15.8 percent overall increase in the detection of cervical precancers and time to detection was much shorter (a median of 103 days versus 393 days).

delivered orally as a pill, to prevent buildup of excess tissue in the uterine lining, which may turn into precancer or cancer.

The vaccine could also significantly reduce the time and money spent on detecting and treating precancers, Markowitz says.

Women who receive human papillomavirus (HPV) testing, in addition to a pap smear, receive a faster, more complete diagnosis of possible cervical precancer, according to a study of over 450,000 women by Queen Mary University of London (QMUL) and the University of New Mexico (UNM) Comprehensive Cancer Center.

To address this gap in knowledge, Mirabello and Schiffman teamed up with co-senior author Robert Burk of Albert Einstein College of Medicine to sequence the whole genomes of 5,570 HPV16 - infected cell and tissue samples from women around the world and to identify associations between HPV16 genetic variants and the risk of cervical precancer and cancer.

Researchers here quantified the detection of cervical precancer and cancer by cotesting compared with HPV testing alone at Kaiser Permanente, where 1,208,710 women have undergone triennial cervical cotesting since 2003.

Screening histories preceding cervical cancers (n = 623) and precancers (n = 5,369) were examined to assess the relative contribution of the Pap test and HPV test components in identifying cases.

HPV - negative / Pap test - positive results preceded only small fractions of cases of precancer (3.5 %) and cancer (5.9 %); these cancers were more likely to be regional or distant stage than other cases.

The analysis found that HPV testing identified more women subsequently diagnosed with cancer and precancer than the Pap test.

An HPV test, in which doctors test a cervicovaginal specimen for the presence of the nucleic acids of carcinogenic types of HPV, is more sensitive than the Pap test (a microscopic examination of exfoliated cells) for detection of precancers.

However, the researchers determined that two proteins can play a significant role in ruling out precancer and cancer.

Mahadevan - Jansen A, Richards - Kortum R. Raman Spectroscopy for the Detection of Cancers and Precancers.

More than a dozen experimental clinical therapies and vaccines have been developed from research from the Weiner laboratory, including the first Zika vaccine in clinical trials, as well as a novel immunotherapy for HPV - associated cancer and precancer.

«We understand that people get infections, we understand that people develop low - grade abnormalities, but we also understand that the amount of precancer is very low in these populations,» says Wheeler, who has conducted extensive research on HPV infection and cervical cancer.

While Gardasil has been approved for the prevention of cancers and precancers of the cervix, anus, vulva, and vagina, it so far has not been approved for the prevention of penile or oropharyngeal cancer.